home

GILD.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare

symbollastchange%chngnamemcapsectorwiki
GILD
US
Gilead Sciences Inc

News graph GILD.US

News chart for GILD

Bold candlesticks represent price chart. Light bars represent news sentiment.

Todays news for GILD

Gilead Sciences, Inc. (NASDAQ:GILD) Declares $0.77 Quarterly Dividend - theenterpriseleader
2h ago - GILD - story
Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - yahoo
3h ago - GILD - story
Gilead gives up on $4.9B antibody magrolimab - fiercebiotech
15h ago - GILD - story
Cardington softball gets home win over Mount Gilead - Morrow County Sentinel - morrowcountysentinel
20:30 Fri - GILD - story
Biktarvy Label Update Adds Data on Safety, Efficacy in Pregnant HIV Patients - empr
19:00 Fri - GILD - story
Gilead Stock Gives Up Big Gains As Covid Drug Drives Its Beat — Again - investors
17:30 Fri - GILD - story
FDA Approves Biktarvy Label Update With Data for Pregnant Adults With HIV - wallstreet-online de
14:30 Fri - GILD - story
Gilead Sciences Says FDA OK's Updated Label Of Biktarvy To Treat Pregnant People With HIV-1 - rttnews
14:00 Fri - GILD - story
Gilead Sciences Says FDA OK's Updated Label Of Biktarvy To Treat Pregnant People With HIV-1 - finanznachrichten de
13:45 Fri - GILD - story
Gilead Sciences (NASDAQ:GILD) Receives "Hold" Rating from Needham & Company LLC - dailypolitical
13:00 Fri - GILD - story
Gilead Sciences (NASDAQ:GILD) Receives "Hold" Rating from Needham & Company LLC - tickerreport
13:00 Fri - GILD - story
Gilead Sciences (GILD) Announces FDA Approves Biktarvy Label Update With Data For Pregnant Adults With HIV - streetinsider
13:00 Fri - GILD - story
GILD Stock Earnings: Gilead Sciences Beats EPS, Beats Revenue for Q1 2024 - biztoc
01:00 Fri - GILD - story

High impact previous days news for GILD ( full news )

Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - yahoo
Sat 27 Apr - GILD - link story
GILD Stock Earnings: Gilead Sciences Beats EPS, Beats Revenue for Q1 2024 - biztoc
Fri 26 Apr - GILD - link story
Gilead Sciences Inc (GILD) Q1 2024 Earnings: Misses Analyst EPS Estimates Amid Significant ... - yahoo
Thu 25 Apr - GILD - link story
Galapagos (NASDAQ:GLPG) and Vivesto (OTCMKTS:OASMY) Head to Head Survey - theenterpriseleader
Wed 24 Apr - GILD - link story
Head-To-Head Comparison: Galapagos (NASDAQ:GLPG) versus Vivesto (OTCMKTS:OASMY) - dailypolitical
Wed 24 Apr - GILD - link story
StockNews.com Downgrades Gilead Sciences (NASDAQ:GILD) to Buy - themarketsdaily
Tue 23 Apr - GILD - link story
Gilead Sciences' (GILD) Outperform Rating Reaffirmed at Oppenheimer - theenterpriseleader
Tue 23 Apr - GILD - link story
Gilead Sciences, Inc. (NASDAQ:GILD) Stake Increased by MCF Advisors LLC - themarketsdaily
Mon 22 Apr - GILD - link story
abrdn plc Raises Position in Gilead Sciences, Inc. (NASDAQ:GILD) - wkrb13
Sat 20 Apr - GILD - link story
Twin Capital Management Inc. Increases Holdings in Gilead Sciences, Inc. (NASDAQ:GILD) - dailypolitical
Thu 18 Apr - GILD - link story
Twin Capital Management Inc. Increases Holdings in Gilead Sciences, Inc. (NASDAQ:GILD) - themarketsdaily
Thu 18 Apr - GILD - link story
Metastatic Colorectal Cancer Treatment Market Size 2024 - openpr
Sun 14 Apr - GILD - link story
Gilead's Veklury receives NICE recommendation to treat COVID-19 in vulnerable adults and children - pmlive
Fri 12 Apr - GILD - link story
3 Stocks at 52-Week Lows Poised for a Powerful Rebound - investorplace
Wed 10 Apr - GILD - link story
Park Place Capital Corp Cuts Stake in Gilead Sciences, Inc. (NASDAQ:GILD) - themarketsdaily
Fri 5 Apr - GILD - link story
Park Place Capital Corp Cuts Stake in Gilead Sciences, Inc. (NASDAQ:GILD) - dailypolitical
Fri 5 Apr - GILD - link story
Got $5,000? These 3 High-Yielding Dividend Stocks Are Trading Near Their 52-Week Lows - fool
Fri 5 Apr - GILD - link story
Gilead Sciences, Inc. (NASDAQ:GILD) Stock Holdings Lowered by Coastline Trust Co - theenterpriseleader
Wed 3 Apr - GILD - link story
Farmers & Merchants Investments Inc. Sells 237 Shares of Gilead Sciences, Inc. (NASDAQ:GILD) - tickerreport
Wed 3 Apr - GILD - link story
Galapagos Downgraded, Pharma Firm Faces Uphill Battle With Slow Pipeline Progress - Galapagos (NASDAQ:GLPG) - benzinga
Mon 1 Apr - GILD - link story
Xilio Therapeutics (XLO) Announces $11.3 Million Private Placement Equity Financing, License Agreement with Gilead (GILD) - streetinsider
Thu 28 Mar - GILD - link story
Xilio Therapeutics Plans Private Placement, Job Cuts - marketscreener
Thu 28 Mar - GILD - link story
Gilead Sciences (NASDAQ:GILD) Stock Rating Upgraded by StockNews.com - theenterpriseleader
Thu 28 Mar - GILD - link story
Everest Medicines Announces Financial Results for Full Year Ended December 31, 2023 - prnewswire
Thu 28 Mar - GILD - link story
Gilead man dies in Jefferson County crash, officials say - journalstar
Wed 27 Mar - GILD - link story
Bill Few Associates Inc. Lowers Holdings in Gilead Sciences, Inc. (NASDAQ:GILD) - dailypolitical
Mon 25 Mar - GILD - link story
Gilead Sher | The Age - theage au
Mon 18 Mar - GILD - link story
Good news: Brain cancer researchers make a breakthrough - deccanherald
Sun 17 Mar - GILD - link story
Gilead Sciences : Kite Cell Therapy Analyst & Investor Event -March 14, 2024 at 06:41 pm EDT - marketscreener
Fri 15 Mar - GILD - link story
AHF • Protesters Keep Heat on Greedy Gilead over Price Gouging - aidshealth org
Wed 13 Mar - GILD - link story
Protesters Keep Heat on Greedy Gilead over Price Gouging - valdostadailytimes
Wed 13 Mar - GILD - link story
Protesters Keep Heat on Greedy Gilead over Price Gouging - streetinsider
Wed 13 Mar - GILD - link story
Judge slaps down Big Pharma's attack on drug price cuts - dominionpost
Sun 10 Mar - GILD - link story
Gilead Sciences Signs Yet Another R&D Alliance for Multi-Target Cancer Therapies - medcitynews
Thu 7 Mar - GILD - link story
Zidovudine Market SWOT Analysis by Leading Key Players: Gilead - openpr
Tue 27 Feb - GILD - link story
Certified Advisory Corp Sells 593 Shares of Gilead Sciences, Inc. (NASDAQ:GILD) - theenterpriseleader
Fri 23 Feb - GILD - link story
3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024 - investorplace
Fri 23 Feb - GILD - link story
Gilead pauses enrollment for solid tumor trials of cancer drug on high mortality risk - seekingalpha
Fri 16 Feb - GILD - link story
Gilead Sciences: 2024 Catalysts Should Drive Growth And Change In Sentiment (NASDAQ:GILD) - seekingalpha
Fri 16 Feb - GILD - link story
The Market share for Epclusa by Gilead Sciences Set to Experience - openpr
Thu 15 Feb - GILD - link story
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates FANG, CBAY, WISH - eagletribune
Tue 13 Feb - GILD - link story
Itch a wrap: Cymabay PBC story ends with $4.3B Gilead buy - bioworld
Tue 13 Feb - GILD - link story
News Highlights: Top Company News of the Day - Monday at 7 PM ET - marketscreener
Tue 13 Feb - GILD - link story
Gilead Sciences | PressReleasePoint - pressreleasepoint
Sat 10 Feb - GILD - link story
Upsized Kyverna IPO Gets $319M to Bring CAR T-Therapy to Autoimmune Diseases - medcitynews
Fri 9 Feb - GILD - link story
Gilead Discontinues Phase 3 ENHANCE-3 Trial of Magrolimab Plus Venetoclax/Azacitidine in AML - onclive
Fri 9 Feb - GILD - link story
Gilead Ends Development of Magrolimab for Hematologic Cancers - empr
Fri 9 Feb - GILD - link story
Gilead Sciences Full Year 2023 Earnings: EPS Misses Expectations - yahoo
Thu 8 Feb - GILD - link story
AHF • AHF Hammers Gilead Over Continued Profiteering - aidshealth org
Thu 8 Feb - GILD - link story
Gilead will decide March 30 on building updates at town meeting - sunjournal
Thu 8 Feb - GILD - link story
``` ```